Roseola risk factors: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 2: | Line 2: | ||
{{Roseola}} | {{Roseola}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{DAMI}} | ||
==Overview== | ==Overview== | ||
The common risk factors in the development of roseola includes infancy (younger 2 years), [[immunosuppression]], and organ transplantation. | |||
==Risk factors== | ==Risk factors== | ||
Risk factors predisposing to roseola infection include: | Risk factors predisposing to roseola infection include: | ||
*Infancy: primary infection usually occurs in children less than 2 years of age | *[[Infancy]]: primary infection usually occurs in children less than 2 years of age | ||
*Immunosuppression in adults with solid organ transplants and patients with HIV infection are at a higher risk of developing complications such as encephalitis | *[[Immunosuppression]] in adults with solid [[organ transplants]] and patients with [[HIV]] infection are at a higher risk of developing complications such as [[encephalitis]]. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Neurology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Dermatology]] | |||
Latest revision as of 00:03, 30 July 2020
|
Roseola Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Roseola risk factors On the Web |
|
American Roentgen Ray Society Images of Roseola risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]
Overview
The common risk factors in the development of roseola includes infancy (younger 2 years), immunosuppression, and organ transplantation.
Risk factors
Risk factors predisposing to roseola infection include:
- Infancy: primary infection usually occurs in children less than 2 years of age
- Immunosuppression in adults with solid organ transplants and patients with HIV infection are at a higher risk of developing complications such as encephalitis.